Conscious sedation for office hysteroscopy: A systematic review and meta-analysis. (November 2021)
- Record Type:
- Journal Article
- Title:
- Conscious sedation for office hysteroscopy: A systematic review and meta-analysis. (November 2021)
- Main Title:
- Conscious sedation for office hysteroscopy: A systematic review and meta-analysis
- Authors:
- De Silva, Prathiba M.
Carnegy, Alasdair
Graham, Christopher
Smith, Paul P.
Clark, T. Justin - Abstract:
- Abstract: Objective: To evaluate the role of conscious sedation on pain control in office hysteroscopy. Methods: MEDLINE, EMBASE, CINAHL and CENTRAL were searched from inception to the 30th October 2020 in order to perform a systematic review and meta-analysis of all randomized controlled trials investigating women undergoing office hysteroscopic procedures, allocated to either conscious sedation or a suitable comparator, where the outcome was pain. Data regarding adverse events, feasibility and satisfaction/acceptability were also collected. The Risk of Bias 2 tool was used to assess study quality. Standard mean differences (SMD) or Odds Ratios (OR), and their 95% confidence intervals (CIs) were calculated for continuous (e.g. mean pain) and dichotomous (e.g. side-effects) outcomes, respectively. Results: The literature search returned 339 results, of which seven studies were included for systematic review, with five studies having data suitable for meta-analysis. Intravenous conscious sedation, when compared with local anesthesia, reduced pain during (SMD −0.26, 95% CI −0.51 to −0.01), but not after (SMD −0.18, 95% CI −0.43 to 0.07) office hysteroscopy. No significant difference in side-effects were noted (OR 15.58, 95% CI 0.08 to 2891.91). Intravenous conscious sedation, when compared to an oral analgesic and antispasmodic, was associated with increased pain, both during (SMD 1.03, 95% CI 0.56 to 1.49) and after (SMD 0.49, 95% CI 0.04 to 0.93) hysteroscopy and hadAbstract: Objective: To evaluate the role of conscious sedation on pain control in office hysteroscopy. Methods: MEDLINE, EMBASE, CINAHL and CENTRAL were searched from inception to the 30th October 2020 in order to perform a systematic review and meta-analysis of all randomized controlled trials investigating women undergoing office hysteroscopic procedures, allocated to either conscious sedation or a suitable comparator, where the outcome was pain. Data regarding adverse events, feasibility and satisfaction/acceptability were also collected. The Risk of Bias 2 tool was used to assess study quality. Standard mean differences (SMD) or Odds Ratios (OR), and their 95% confidence intervals (CIs) were calculated for continuous (e.g. mean pain) and dichotomous (e.g. side-effects) outcomes, respectively. Results: The literature search returned 339 results, of which seven studies were included for systematic review, with five studies having data suitable for meta-analysis. Intravenous conscious sedation, when compared with local anesthesia, reduced pain during (SMD −0.26, 95% CI −0.51 to −0.01), but not after (SMD −0.18, 95% CI −0.43 to 0.07) office hysteroscopy. No significant difference in side-effects were noted (OR 15.58, 95% CI 0.08 to 2891.91). Intravenous conscious sedation, when compared to an oral analgesic and antispasmodic, was associated with increased pain, both during (SMD 1.03, 95% CI 0.56 to 1.49) and after (SMD 0.49, 95% CI 0.04 to 0.93) hysteroscopy and had significantly more side-effects (OR 134.33, 95% CI 16.14 to 1118.17). Inhalational conscious sedation (70% N2 O/30% O2 ), when compared to oral analgesia and anxiolysis, showed the greatest reduction in pain during hysteroscopy (SMD −1.04, 95% CI −1.57 to −0.52), however side-effects were not reported. Whilst patients and hysteroscopists were more satisfied with deeper levels of sedation, resulting side-effects, such as delirium, increased the level of post-procedural attention required, leading to a significantly lower level of satisfaction amongst nursing staff. Conclusion: The routine use of conscious sedation in contemporary hysteroscopic practice should be avoided in the absence of any clear reduction in pain and a higher risk of side-effects. … (more)
- Is Part Of:
- European journal of obstetrics, gynecology, and reproductive biology. Volume 266(2021)
- Journal:
- European journal of obstetrics, gynecology, and reproductive biology
- Issue:
- Volume 266(2021)
- Issue Display:
- Volume 266, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 266
- Issue:
- 2021
- Issue Sort Value:
- 2021-0266-2021-0000
- Page Start:
- 89
- Page End:
- 98
- Publication Date:
- 2021-11
- Subjects:
- Nitrous oxide -- Benzodiazepines -- Opioids -- Pain -- Sedative -- Outpatient -- Endoscopy
Obstetrics -- Periodicals
Gynecology -- Periodicals
Reproductive health -- Periodicals
Gynecology -- Periodicals
Obstetrics -- Periodicals
Reproduction -- Periodicals
Obstétrique -- Périodiques
Gynécologie -- Périodiques
Reproduction -- Périodiques
Verloskunde
Gynaecologie
Voortplanting (biologie)
Gynecology
Obstetrics
Reproduction
Electronic journals
Periodicals
Electronic journals
618.05 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03012115 ↗
http://www.ingentaconnect.com/content/els/00282243 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/03012115 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/03012115 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejogrb.2021.09.001 ↗
- Languages:
- English
- ISSNs:
- 0301-2115
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.733000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19856.xml